Breaking News Instant updates and real-time market news.

SPNE

SeaSpine

$17.42

0.095 (0.55%)

16:29
11/06/18
11/06
16:29
11/06/18
16:29

SeaSpine reports Q3 EPS (65c), consensus (48c)

Reports Q3 revenue $35.8M, consensus $35.22M.

  • 06

    Nov

  • 27

    Nov

SPNE SeaSpine
$17.42

0.095 (0.55%)

07/30/18
PIPR
07/30/18
NO CHANGE
Target $16
PIPR
Overweight
SeaSpine capturing market share, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien kept his Overweight rating and $16 price target on SeaSpine after its Q2 results. The analyst notes that the company's investments made over the past quarters are allowing it to capture spine market share and also grow above market rates. O'Brien adds that while SeaSpine trades at a "meaningful discount" relative to its peer group, that gap will be closed over time as the company extends its topline growth.
10/02/18
PIPR
10/02/18
NO CHANGE
Target $20
PIPR
Overweight
SeaSpine price target raised to $20 from $16 at Piper Jaffray
Piper Jaffray analyst Matt O'Brien raised his price target for SeaSpine to $20 from $16 after the company pre-announced Q3 revenues that beat consensus, prompting management to increase its FY18 outlook. The momentum in the quarter was driven by strong market uptake of recently launched products generated by an increasingly exclusive and engaged distributor network, he notes, pointing out that this exemplifies management's execution of a turnaround strategy established three years ago post-spin by first increasing the mindshare of SeaSpine's products within its distributor network as well as attracting new distributor partners with a robust product suite. O'Brien reiterates an Overweight rating on the shares.
10/04/18
CANT
10/04/18
NO CHANGE
Target $22
CANT
Overweight
SeaSpine price target raised to $22 from $16 at Cantor Fitzgerald
Cantor Fitzgerald analyst Craig Bijou raised his price target for SeaSpine to $22 and reiterates an Overweight rating on the shares after hosting a chat with the company's CEO and CFO. The analyst now has more conviction that SeaSpine can consistently deliver growth in the high-single to low-double-digit range. He thinks the company is "finally starting to see the benefit of management's hard work over the last three years." Bijou views SeaSpine's 2018 sales guidance as conservative and sees upside to 2019 consensus estimates.
10/16/18
PIPR
10/16/18
NO CHANGE
PIPR
Piper Jaffray discusses derivatives from J&J's Q3 results
Piper Jaffray analyst Matt O'Brien notes that Johnson & Johnson's (JNJ) global Medical Devices segment grew 1.7% organically in Q3, with sales of $6.6B falling $50M short of the consensus. The large joint segment continues to look relatively stable, with low-single-digit pricing pressures as expected, O'Brien tells investors in a research note. The analyst suspects Stryker (SYK) will continue to take share away from J&J and Zimmer Biomet (ZBH) in Q3. J&J's Spine segment was flat off of easy comps and after normalizing the Codman divestiture, the analyst adds. He continues to view J&J as a "share donor" to the pure-play spine names Globus Medical (GMED), NuVasive (NUVA) and SeaSpine (SPNE), with Globus' robot "continuing to provide share taking opportunities." Within Contact Lenses, J&J faced tough comps but reported a solid quarter in both the domestic and international markets, O'Brien says. He continues to see a "healthy" lens end market and one that is shifting to daily lenses from reusable, which he views as positive for Cooper Companies (COO). Further, the analyst notes that Diabetes continues to decelerate for J&J at a negative 20% clip given the Animas exit, which he thinks continues to be a positive for the pump names Insulet (PODD) and Tandem Diabetes (TNDM).

TODAY'S FREE FLY STORIES

UNH

UnitedHealth

$271.03

5.795 (2.18%)

08:25
02/19/19
02/19
08:25
02/19/19
08:25
Conference/Events
Economic Club of Minnesota to hold a luncheon meeting »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 28

    May

GRMN

Garmin

$71.61

0.2 (0.28%)

08:24
02/19/19
02/19
08:24
02/19/19
08:24
Recommendations
Garmin analyst commentary  »

Garmin likely to issue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

08:24
02/19/19
02/19
08:24
02/19/19
08:24
Conference/Events
Federal Reserve Bank of Cleveland president speaks on the economic outlook »

Cleveland Federal Reserve…

SRTS

Sensus Healthcare

$7.61

-0.13 (-1.68%)

08:23
02/19/19
02/19
08:23
02/19/19
08:23
Recommendations
Sensus Healthcare analyst commentary  »

Roth Capital establishes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLCO

Melco Resorts & Entertainment

$21.76

0.35 (1.63%)

08:23
02/19/19
02/19
08:23
02/19/19
08:23
Earnings
Melco Resorts & Entertainment reports Q4 EPS 27c, consensus 24c »

Reports Q4 revenue $1.4B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:23
02/19/19
02/19
08:23
02/19/19
08:23
Conference/Events
JPMorgan to hold a conference »

Taiwan CEO-CFO Conference…

UNIT

Uniti Group

$20.00

0.53 (2.72%)

08:22
02/19/19
02/19
08:22
02/19/19
08:22
Hot Stocks
Uniti Group issues statement on Windstream court ruling »

Uniti Group issued a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 11

    Mar

08:22
02/19/19
02/19
08:22
02/19/19
08:22
Conference/Events
Nomura to hold a conference »

Japan Corporate Day 2019…

WMT

Walmart

$100.00

1.52 (1.54%)

08:21
02/19/19
02/19
08:21
02/19/19
08:21
Hot Stocks
Breaking Hot Stocks news story on Walmart »

Walmart says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 03

    Mar

  • 06

    Mar

OXY

Occidental Petroleum

$67.17

0.62 (0.93%)

08:21
02/19/19
02/19
08:21
02/19/19
08:21
Downgrade
Occidental Petroleum rating change  »

Occidental Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

  • 28

    May

NWL

Newell Brands

$17.15

-4.55 (-20.97%)

08:21
02/19/19
02/19
08:21
02/19/19
08:21
Recommendations
Newell Brands analyst commentary  »

Newell Brands price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

HAS

Hasbro

$86.43

-3.29 (-3.67%)

, FNKO

Funko

$18.05

-0.64 (-3.42%)

08:21
02/19/19
02/19
08:21
02/19/19
08:21
Conference/Events
Jefferies to hold company meetings at conference »

Jefferies Company Hosted…

HAS

Hasbro

$86.43

-3.29 (-3.67%)

FNKO

Funko

$18.05

-0.64 (-3.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 28

    Feb

  • 06

    Mar

  • 28

    May

CAR

Avis Budget

$28.67

0.66 (2.36%)

, LAD

Lithia Motors

$87.98

4.05 (4.83%)

08:20
02/19/19
02/19
08:20
02/19/19
08:20
Hot Stocks
Avis Budget announces John North to be named CFO »

Avis Budget (CAR)…

CAR

Avis Budget

$28.67

0.66 (2.36%)

LAD

Lithia Motors

$87.98

4.05 (4.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 14

    Mar

  • 20

    Mar

  • 21

    Mar

LH

LabCorp

$150.15

3.34 (2.28%)

08:19
02/19/19
02/19
08:19
02/19/19
08:19
Hot Stocks
LabCorp announces new assay in DoseASSURE portfolio »

LabCorp announced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$100.00

1.52 (1.54%)

08:18
02/19/19
02/19
08:18
02/19/19
08:18
Hot Stocks
Breaking Hot Stocks news story on Walmart »

Walmart says operating in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 03

    Mar

  • 06

    Mar

WMT

Walmart

$100.00

1.52 (1.54%)

08:17
02/19/19
02/19
08:17
02/19/19
08:17
Hot Stocks
Breaking Hot Stocks news story on Walmart »

Walmart sees pace of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 03

    Mar

  • 06

    Mar

NVEE

NV5 Global

$76.56

0.49 (0.64%)

08:17
02/19/19
02/19
08:17
02/19/19
08:17
Hot Stocks
NV5 Global secures more than $11M in program management services »

NV5 Global announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

08:16
02/19/19
02/19
08:16
02/19/19
08:16
Conference/Events
Consumer Analyst Group of New York holds a conference »

CAGNY Conference 2019…

OXY

Occidental Petroleum

$67.17

0.62 (0.93%)

08:16
02/19/19
02/19
08:16
02/19/19
08:16
Downgrade
Occidental Petroleum rating change  »

Occidental Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

  • 28

    May

ECOR

ElectroCore

$6.82

-0.53 (-7.21%)

08:15
02/19/19
02/19
08:15
02/19/19
08:15
Hot Stocks
ElectroCore announces partnership with HealthyWomen »

ElectroCore announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$100.00

1.52 (1.54%)

08:14
02/19/19
02/19
08:14
02/19/19
08:14
Hot Stocks
Walmart says company needs to make more progress on profitability »

Comments taken from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 03

    Mar

  • 06

    Mar

MTFB

Motif Bio

$2.67

-0.14 (-4.98%)

08:14
02/19/19
02/19
08:14
02/19/19
08:14
Conference/Events
Motif Bio to hold a conference call »

Management provides an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

MCO

Moody's

$169.20

5.72 (3.50%)

08:14
02/19/19
02/19
08:14
02/19/19
08:14
Recommendations
Moody's analyst commentary  »

Moody's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

  • 09

    Apr

MRVL

Marvell

$18.82

-0.37 (-1.93%)

08:13
02/19/19
02/19
08:13
02/19/19
08:13
Upgrade
Marvell rating change  »

Marvell upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

  • 25

    Mar

  • 26

    Mar

EDRY

EuroDry

$7.85

-0.02 (-0.25%)

08:12
02/19/19
02/19
08:12
02/19/19
08:12
Earnings
EuroDry reports Q4 adj. EPS 31c, consensus 17c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.